Bernt van den Blink

3.5k citations

50 papers · 2.5k indexed · h-index 27

Pulmonary and Respiratory Medicine top 2%
Physiology top 2%
Immunology top 5%
Molecular Biology
Epidemiology top 10%

Co-authors: Maikel P. Peppelenbosch Henk C. Hoogsteden Mirjam Kool Rudi W. Hendriks Marlies Wijsenbeek Tom van der Poll Sander J. H. van Deventer Caroline E. Broos
Topics: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (24 papers)Sarcoidosis and Beryllium Toxicity Research (13 papers)Inflammatory Bowel Disease (5 papers)
Cited by: Pulmonary and Respiratory Medicine Physiology Immunology
Journals: JAMA Blood The Journal of Immunology
Partner nations: Netherlands United States Germany

In The Last Decade

Bernt van den Blink

49 papers receiving 2.4k citations

Peers

Countries citing papers authored by Bernt van den Blink

Since Specialization

Citations

This map shows the geographic impact of Bernt van den Blink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernt van den Blink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernt van den Blink more than expected).

Fields of papers citing papers by Bernt van den Blink

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernt van den Blink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernt van den Blink. The network helps show where Bernt van den Blink may publish in the future.

Co-authorship network of co-authors of Bernt van den Blink

This figure shows the co-authorship network connecting the top 25 collaborators of Bernt van den Blink. A scholar is included among the top collaborators of Bernt van den Blink based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernt van den Blink. Bernt van den Blink is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	ISABELA Studies: Plasma Exposure and Target Engagement Do Not Explain the Lack of Efficacy of Ziritaxestat in Patients with Idiopathic Pulmonary Fibrosis 2023 ·Clinical Pharmacology & Therapeutics ·Amit Taneja,Garrit Jentsch,(unknown),Matthew J. Randall,Bernt van den Blink,Yasmina Bauer,Florence Namour	4
2	Increased T-helper 17.1 cells in sarcoidosis mediastinal lymph nodes 2018 ·European Respiratory Journal ·Caroline E. Broos,Laura L. Koth,Menno van Nimwegen,J.C.C.M. in ’t Veen,Sandra M. J. Paulissen,Jan Piet van Hamburg,Jouke T. Annema,Roxane Heller-Baan,Alex KleinJan,Henk C. Hoogsteden,Marlies Wijsenbeek,Rudi W. Hendriks,Bernt van den Blink,Mirjam Kool	83
3	What patients with pulmonary fibrosis and their partners think: a live, educative survey in the Netherlands and Germany 2017 ·ERJ Open Research ·Mirjam J.G. van Manen,Michael Kreuter,Bernt van den Blink,Ute Oltmanns,Karin Palmowski,(unknown),Simone Hummler,(unknown),(unknown),Jelle Miedema,Henk C. Hoogsteden,Marlies Wijsenbeek	27
4	Recombinant human pentraxin-2 therapy in patients with idiopathic pulmonary fibrosis: safety, pharmacokinetics and exploratory efficacy 2016 ·European Respiratory Journal ·Bernt van den Blink,(unknown),Leo C. Ginns,Lake Morrison,Matthijs Moerland,Marlies Wijsenbeek,Elizabeth Trehu,Brian J. Bartholmai,Jacobus Burggraaf	77
5	Idiopathische pulmonale fibrose : nieuwe inzichten 2015 ·Data Archiving and Networked Services (DANS) ·(unknown),Bernt van den Blink,Leon M. van den Toorn,Paul Bresser,Frouke T. van Beek,J.C. Grutters,Marlies Wijsenbeek	0
6	IFN-γ–Producing T-Helper 17.1 Cells Are Increased in Sarcoidosis and Are More Prevalent than T-Helper Type 1 Cells 2015 ·American Journal of Respiratory and Critical Care Medicine ·Joris Ramstein,Caroline E. Broos,Laura J. Simpson,K. Mark Ansel,Sara A. Sun,Melissa Ho,Prescott G. Woodruff,Nirav R. Bhakta,Laura S. Christian,Christine Nguyen,(unknown),Bryan S. Benn,Rudi W. Hendriks,Bernt van den Blink,Mirjam Kool,Laura L. Koth	187
7	Impaired survival of regulatory T cells in pulmonary sarcoidosis 2015 ·Respiratory Research ·Caroline E. Broos,Menno van Nimwegen,Alex KleinJan,(unknown),Femke Muskens,J.C.C.M. in ’t Veen,Jouke T. Annema,Bart N. Lambrecht,Henk C. Hoogsteden,Rudi W. Hendriks,Mirjam Kool,Bernt van den Blink	49
8	Ten-Year Survival in Patients with Idiopathic Pulmonary Fibrosis After Lung Transplantation 2015 ·Lung ·(unknown),(unknown),Johanna M. Kwakkel‐van Erp,Diana A. van Kessel,(unknown),Ed A. van de Graaf,Bart Luijk,Rogier A.S. Hoek,Bernt van den Blink,(unknown),Erik A.M. Verschuuren,Wim van der Bij,Coline HM van Moorsel,Jan C. Grutters	15
9	Mode of dendritic cell activation: The decisive hand in Th2/Th17 cell differentiation. Implications in asthma severity? 2014 ·Immunobiology ·Heleen Vroman,Bernt van den Blink,Mirjam Kool	70
10	Recombinant human serum amyloid P in healthy volunteers and patients with pulmonary fibrosis 2013 ·Pulmonary Pharmacology & Therapeutics ·(unknown),Bernt van den Blink,Matthijs Moerland,Marloes G. J. van Dongen,Micha Levi,Alex KleinJan,Marlies Wijsenbeek,Mark Lupher,Diane M. Harper,(unknown),Henk C. Hoogsteden,Jacobus Burggraaf	86
11	Protease-Activated Receptor-2 Induces Myofibroblast Differentiation and Tissue Factor Up-Regulation during Bleomycin-Induced Lung Injury 2010 ·American Journal Of Pathology ·Keren Borensztajn,Paul Bresser,Chris van der Loos,Ilze Bot,Bernt van den Blink,Michael A. den Bakker,Joost Daalhuisen,A.P. de Groot,Maikel P. Peppelenbosch,Jan H. von der Thüsen,C. Arnold Spek	49
12	A novel method for isolating dendritic cells from human bronchoalveolar lavage fluid 2009 ·Journal of Immunological Methods ·(unknown),Femke Muskens,Alex KleinJan,Hamida Hammad,H. C. Hoogsteden,Bart N. Lambrecht,Bernt van den Blink	14
13	Specific Inhibition of c-Raf Activity by Semapimod Induces Clinical Remission in Severe Crohn’s Disease 2005 ·The Journal of Immunology ·Mark Löwenberg,Auke P. Verhaar,Bernt van den Blink,Fibo Ten Kate,Sander van Deventer,Maikel P. Peppelenbosch,Daniël W. Hommes	41
14	Procoagulant protein levels are differentially increased during human endotoxemia 2003 ·Journal of Thrombosis and Haemostasis ·Pieter H. Reitsma,Judith Branger,Bernt van den Blink,Sebastiaan Weijer,Tom van der Poll,Joost C.M. Meijers	35
15	Anti-Inflammatory Effects of a p38 Mitogen-Activated Protein Kinase Inhibitor During Human Endotoxemia 2002 ·The Journal of Immunology ·Judith Branger,Bernt van den Blink,Sebastiaan Weijer,Jeffrey B. Madwed,Carina L. Bos,Abhya Gupta,Chan‐Loi Yong,Stephen H. Polmar,Dariusz P. Olszyna,C. Erik Hack,Sander J. H. van Deventer,Maikel P. Peppelenbosch,Tom van der Poll	203
16	Immunomodulatory effect of oxygen and pressure 2002 ·Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology ·Bernt van den Blink,(unknown),Henri H. Versteeg,Maikel P. Peppelenbosch	23
17	Inhibition of stress-activated MAP kinases induces clinical improvement in moderate to severe Crohn's disease 2002 ·Gastroenterology ·Daan W. Hommes,Bernt van den Blink,Terry F. Plasse,J. F. W. M. Bartelsman,Cuiping Xu,(unknown),Guido N.J. Tytgat,Maikel P. Peppelenbosch,Sander van Deventer	307
18	From Extracellular to Intracellular Targets, Inhibiting MAP Kinases in Treatment of Crohn's Disease 2002 ·Annals of the New York Academy of Sciences ·Bernt van den Blink,Tessa ten Hove,Gijs R. van den Brink,Maikel P. Peppelenbosch,Sander J. H. van Deventer	24
19	p38 Mitogen-Activated Protein Kinase Inhibition Increases Cytokine Release by Macrophages In Vitro and During Infection In Vivo 2001 ·The Journal of Immunology ·Bernt van den Blink,Nicole P. Juffermans,Tessa ten Hove,(unknown),Sander J. H. van Deventer,Tom van der Poll,Maikel P. Peppelenbosch	97
20	Human Endotoxemia Activates p38 MAP Kinase and p42/44 MAP Kinase, But Not c-Jun N-terminal Kinase 2001 ·Molecular Medicine ·Bernt van den Blink,Judith Branger,Sebastiaan Weijer,Sander J. H. van Deventer,Tom van der Poll,Maikel P. Peppelenbosch	15

About Bernt van den Blink

Bernt van den Blink is a scholar working on Immunology, Pulmonary and Respiratory Medicine and Physiology, having authored 50 papers that have together received 2.5k indexed citations. Recurring topics across this work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (24 papers), Sarcoidosis and Beryllium Toxicity Research (13 papers) and Inflammatory Bowel Disease (5 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (1.1k citations), Physiology (809 citations) and Immunology (568 citations). Bernt van den Blink has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Maikel P. Peppelenbosch, Henk C. Hoogsteden, Mirjam Kool, Rudi W. Hendriks, Marlies Wijsenbeek, Tom van der Poll, Sander J. H. van Deventer, Caroline E. Broos, Sander van Deventer and Judith Branger. Their work appears in journals such as JAMA, Blood and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact